We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.01B
AUM Growth
-$138M
Cap. Flow
-$174M
Cap. Flow %
-17.28%
Top 10 Hldgs %
26.38%
Holding
127
New
17
Increased
17
Reduced
26
Closed
9

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$19.7M
2
GILD icon
Gilead Sciences
GILD
+$19.1M
3
LLY icon
Eli Lilly
LLY
+$16.1M
4
SO icon
Southern Company
SO
+$15.7M
5
HD icon
Home Depot
HD
+$15.2M

Top Sells

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$26.3M
2
JNJ icon
Johnson & Johnson
JNJ
+$20.3M
3
CME icon
CME Group
CME
+$18M
4
IBM icon
IBM
IBM
+$17.9M
5
KO icon
Coca-Cola
KO
+$14.3M

Sector Composition

Rank Sector Weight
1 Financials 15.74%
2 Technology 12.46%
3 Healthcare 10.79%
4 Consumer Staples 10.29%
5 Energy 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCE icon
51
BCE
BCE
$19.9B
$11.3M 1.12%
240,600
+42,100
+21% +$1.97M
BTI icon
52
British American Tobacco
BTI
$132B
$11.2M 1.12%
+180,021
New +$11.6M
STI
53
DELISTED
SunTrust Banks, Inc.
STI
$11.2M 1.12%
+188,000
New +$10.6M
KHC icon
54
Kraft Heinz
KHC
$30.4B
$11.1M 1.11%
143,700
-91,900
-39% -$7.69M
EMR icon
55
Emerson Electric
EMR
$82.9B
$11M 1.09%
175,100
PNC icon
56
PNC Financial Services
PNC
$100B
$9.65M 0.96%
+71,600
New +$9.19M
C icon
57
Citigroup
C
$222B
$9.56M 0.95%
+131,400
New +$8.97M
DUK icon
58
Duke Energy
DUK
$102B
$9.17M 0.91%
109,300
BUD icon
59
AB InBev
BUD
$158B
$9.09M 0.9%
76,200
SBUX icon
60
Starbucks
SBUX
$118B
$8.34M 0.83%
+155,200
New +$8.6M
TGT icon
61
Target
TGT
$62.1B
$3.69M 0.37%
62,600
-196,200
-76% -$11M
KO icon
62
Coca-Cola
KO
$354B
$3.64M 0.36%
80,800
-313,900
-80% -$14.3M
XOM icon
63
ExxonMobil
XOM
$651B
$3.14M 0.31%
38,256
-138,400
-78% -$11M
IBM icon
64
IBM
IBM
$202B
$3.13M 0.31%
22,594
-128,553
-85% -$17.9M
RGC
65
DELISTED
Regal Entertainment Group
RGC
$3.04M 0.3%
190,000
-433,300
-70% -$7.47M
GE icon
66
GE Aerospace
GE
$367B
$2.82M 0.28%
24,330
QCOM icon
67
Qualcomm
QCOM
$176B
$2.43M 0.24%
46,900
-247,800
-84% -$13.1M
FEZ icon
68
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.28B
$2.18M 0.22%
52,890
XLF icon
69
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
$2.08M 0.21%
+80,405
New +$2.01M
LYB icon
70
LyondellBasell Industries
LYB
$19.5B
$2M 0.2%
20,200
F icon
71
Ford
F
$57.3B
$1.94M 0.19%
162,000
-543,000
-77% -$6.12M
TLH icon
72
iShares 10-20 Year Treasury Bond ETF
TLH
$11B
$1.93M 0.19%
14,164
+250
+2% +$34.3K
OXY icon
73
Occidental Petroleum
OXY
$57B
$1.86M 0.18%
28,900
-123,300
-81% -$7.51M
KMB icon
74
Kimberly-Clark
KMB
$36.4B
$1.68M 0.17%
14,300
-116,100
-89% -$14.2M
GIS icon
75
General Mills
GIS
$19.2B
$1.5M 0.15%
29,000
-167,500
-85% -$9.18M

Similar funds

Payden & Rygel's Q3 2017 Portfolio in Review

As of Q3 2017, Payden & Rygel held 127 positions worth $1.01B, down 12% from $1.14B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Payden & Rygel withdrew a net $174M in Q3 2017, closing 9 positions and reducing 26 holdings. Its most notable exit was Reynolds American Inc, an estimated $26.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Payden & Rygel opened a new position in Texas Instruments worth $21.5M.

  • Payden & Rygel's largest Q3 2017 buy was Texas Instruments: 239,900 shares worth $21.5M.
  • Payden & Rygel added most to Gilead Sciences in Q3 2017, an estimated $19.1M increase.
  • Payden & Rygel's biggest Q3 2017 reduction was Johnson & Johnson, cutting an estimated $20.3M.
  • Payden & Rygel fully exited Reynolds American Inc in Q3 2017, selling an estimated $26.3M.
  • Payden & Rygel's ten largest holdings make up 26% of its $1.01B portfolio in Q3 2017.
  • Payden & Rygel opened 17 new positions and closed 9 in Q3 2017.
  • Payden & Rygel's portfolio value fell 12% quarter-over-quarter to $1.01B.

Based on Payden & Rygel's 13F filing for Q3 2017, filed 14 Nov 2017.